Non Hodgkin Lymphoma News and Research

RSS
Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Hospitals battle for control over fast-growing heart-valve procedure

Hospitals battle for control over fast-growing heart-valve procedure

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

FDA approves drug for rare, hard-to-treat types of non-Hodgkin lymphoma

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

CTI BioPharma announces Phase III results of PIXUVRI combined with rituximab in aggressive B-cell NHL patients

Drug used in stem cell therapy may protect against smoke-induced lung injury

Drug used in stem cell therapy may protect against smoke-induced lung injury

Some tumors use two levels of protection against immune system, shows study

Some tumors use two levels of protection against immune system, shows study

Study finds increase in lifestyle-related cancers over the past decade

Study finds increase in lifestyle-related cancers over the past decade

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New 'lymphoma micro-reactor' device targets chemo-resistant tumors

New insights into breast implant-associated anaplastic large-cell lymphoma

New insights into breast implant-associated anaplastic large-cell lymphoma

Researchers propose alternative treatment to target lymphoma signaling at its root

Researchers propose alternative treatment to target lymphoma signaling at its root

Gene-editing technology enhances T cell immunotherapies for treating cancer

Gene-editing technology enhances T cell immunotherapies for treating cancer

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Caris Life Sciences reveals identification of new mechanism of action to treat NHL

Researchers question exclusion of people with prior cancer history from clinical trials

Researchers question exclusion of people with prior cancer history from clinical trials

California cracks down on weed killer as lawsuits abound

California cracks down on weed killer as lawsuits abound

New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma